Precision for Medicine is the first global, precision-medicine, clinical research organization. Purpose-built to shift the development curve for life sciences clients, Precision for Medicine incorporates laboratory expertise, clinical trial excellence, and advanced data sciences at every stage. This integrated approach enables the company to deliver critical insights into patient biology from early development through approval.

CEO

Mark Clein, Co-Founder & CEO

OAK HC/FT PARTNERS

Annie Lamont & Andrew Adams

Sector

Investment Stage

Status

Healthcare

Growth

Private